Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 87%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,365
Total Claims
$1.1M
Drug Cost
764
Beneficiaries
$1,388
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-35%
Opioid rate vs peers
1.7% vs 2.6% avg
+30%
Cost per patient vs peers
$1,388 vs $1,068 avg
+29%
Brand preference vs peers
11.6% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.7%
Opioid Rate
157
Opioid Claims
$2,697
Opioid Cost
15.3%
Long-Acting Rate
Brand vs Generic
Brand: 1,073 claims · $846K
Generic: 8,194 claims · $210K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Fluticasone/Umeclidin/Vilanter | 96 | $125K |
| Sitagliptin Phosphate | 67 | $109K |
| Apixaban | 81 | $100K |
| Empagliflozin | 51 | $89K |
| Dulaglutide | 23 | $60K |
| Rivaroxaban | 23 | $37K |
| Insulin Glargine,hum.Rec.Anlog | 47 | $37K |
| Umeclidinium Brm/Vilanterol Tr | 18 | $24K |
| Mirabegron | 25 | $20K |
| Tiotropium Bromide | 16 | $19K |
| Budesonide/Formoterol Fumarate | 13 | $15K |
| Insulin Detemir | 18 | $14K |
| Linagliptin | 16 | $13K |
| Fluticasone Propion/Salmeterol | 18 | $13K |
| Fluticasone/Vilanterol | 21 | $13K |
Prescribing Profile
Patient Profile
74
Avg Age
50%
Female
0.94
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About